Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 8 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Whitehead Institute for Biomedical Research currently faces 11 pending office actions, all situated within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 10 distinct examiners and 9 distinct art units. NOBLE, MARCIA STEPHENS is identified as the busiest examiner, responsible for 2 of the pending cases.
The presence of 10 distinct examiners for the 11 pending office actions suggests that the portfolio is not concentrated under a few individuals. Instead, the institute must navigate the requirements of the 9 distinct art units. This distribution requires a prosecution strategy that can adapt to the different examination cultures present across these units.
With NOBLE, MARCIA STEPHENS handling 2 pending cases, this examiner represents the point of overlap where an individual manages multiple matters. For the remaining pending office actions, the institute deals with many separate examiners. This lack of concentration means that success in any given matter is unlikely to provide direct procedural momentum for others.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (30%) |
| §112 only | 3 (30%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOBLE, MARCIA STEPHENS | 2 | 67.2% | +39.5% |
| LEE, JAE W | 1 | 65.6% | +38.5% |
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
| MEAH, MOHAMMAD Y | 1 | 70.7% | +42.8% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
| HUDSON, AMY ROSE | 1 | 74.8% | +11.7% |
| DHAR, MATASHA | 1 | 43.5% | +44.8% |
| PERREIRA, MELISSA JEAN | 1 | 52.1% | +25.7% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 68.3% | +46.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 124d overdue |
| 17318921 | THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR APOE4-RELATED DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 42d overdue |
| 18350985 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | MEAH, MOHAMMAD Y | 9d |
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
| Art Unit | Apps |
|---|---|
| 1632 | 3 |
| 1656 | 1 |
| 1637 | 1 |
| 1652 | 1 |
| 1682 | 1 |
| 1636 | 1 |
| 1618 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | 1632 | §103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | 1656 | §103§112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18350985 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | MEAH, MOHAMMAD Y | 1652 | §112 | Non-Final OA | 9d | Pending | Jul 12, 2023 |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 1636 | §112 | Final Rejection | 124d overdue | Pending | Jul 20, 2022 |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | DHAR, MATASHA | 1632 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17318921 | THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR APOE4-RELATED DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Final Rejection | 42d overdue | Pending | May 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWhitehead Institute for Biomedical Research has 10 pending office actions as of October 2026, spread across 8 art units and 9 examiners.
Marcia Stephens Noble has the most, with 2 of Whitehead Institute for Biomedical Research's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
